Suppr超能文献

自身免疫性胰腺炎患者骨骼肌丢失和肌少症的患病率及危险因素

Prevalence and risk factors of skeletal muscle loss and sarcopenia in patients with autoimmune pancreatitis.

作者信息

Sano Takanori, Kikuta Kazuhiro, Matsumoto Ryotaro, Takikawa Tetsuya, Hamada Shin, Miura Shin, Kume Kiyoshi, Masamune Atsushi

机构信息

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

出版信息

Hepatobiliary Pancreat Dis Int. 2025 Aug;24(4):396-403. doi: 10.1016/j.hbpd.2025.05.002. Epub 2025 May 23.

Abstract

BACKGROUND

Previous studies have highlighted the frequent occurrence of sarcopenia in patients with pancreatic diseases, including chronic pancreatitis. We aimed to clarify the prevalence of skeletal muscle (SM) loss and sarcopenia, and their associations with clinical characteristics, bone mineral density, and pancreatic imaging findings in patients with autoimmune pancreatitis (AIP).

METHODS

This study included 114 patients with AIP treated at Tohoku University Hospital. The SM index was assessed using a bioelectrical impedance analysis device, grip strength was measured using a hand dynamometer, and bone mineral density was evaluated using dual-energy X-ray absorptiometry. Univariate and multivariate logistic regression analyses were used to analyze factors associated with SM loss and sarcopenia.

RESULTS

Among 114 patients, 57 (50.0%) had SM loss, 31 (27.2%) had reduced grip strength, and 27 (23.7%) had both. Patients with SM loss were older and had a lower body mass index, weaker grip strength, higher Controlling Nutritional Status scores, and lower serum lipase and albumin levels compared to those without SM loss. Computed tomography scans revealed a higher prevalence of pancreatic parenchymal atrophy in patients with SM loss. Similar differences were observed between patients with sarcopenia and those without. Osteopathy was observed in 35.6% of patients with SM loss and 38.1% of those with sarcopenia, whereas only 4.1% of patients without SM loss had osteopathy. Low BMI (< 21.0 kg/m) was also found to be an independent risk factor for SM loss in multivariate analysis. Age > 72 years, low BMI (< 20.0 kg/m), and low serum lipase levels (< 13 U/L) were independent risk factors for sarcopenia in multivariate analysis.

CONCLUSIONS

SM loss and sarcopenia are prevalent in patients with AIP and are associated with aging, poor nutritional status, low serum lipase levels, and pancreatic parenchymal atrophy. In addition to the high risk of osteopathy, careful attention should be paid to maintain muscle health in AIP patients.

摘要

背景

既往研究强调了包括慢性胰腺炎在内的胰腺疾病患者中肌肉减少症的频繁发生。我们旨在阐明自身免疫性胰腺炎(AIP)患者骨骼肌(SM)丢失和肌肉减少症的患病率,及其与临床特征、骨密度和胰腺影像学表现的相关性。

方法

本研究纳入了在东北大学医院接受治疗的114例AIP患者。使用生物电阻抗分析仪评估SM指数,使用握力计测量握力,并使用双能X线吸收法评估骨密度。采用单因素和多因素逻辑回归分析来分析与SM丢失和肌肉减少症相关的因素。

结果

在114例患者中,57例(50.0%)有SM丢失,31例(27.2%)握力降低,27例(23.7%)两者均有。与无SM丢失的患者相比,有SM丢失的患者年龄更大,体重指数更低,握力更弱,控制营养状况评分更高,血清脂肪酶和白蛋白水平更低。计算机断层扫描显示,有SM丢失的患者胰腺实质萎缩的患病率更高。肌肉减少症患者和无肌肉减少症患者之间也观察到类似差异。在有SM丢失的患者中,35.6%出现骨病,在有肌肉减少症的患者中,38.1%出现骨病,而在无SM丢失的患者中,只有4.1%出现骨病。在多因素分析中,低体重指数(<21.0kg/m²)也是SM丢失的独立危险因素。在多因素分析中,年龄>72岁、低体重指数(<20.0kg/m²)和低血清脂肪酶水平(<13U/L)是肌肉减少症的独立危险因素。

结论

SM丢失和肌肉减少症在AIP患者中普遍存在,并且与衰老、营养状况差、血清脂肪酶水平低和胰腺实质萎缩有关。除了骨病风险高之外,还应密切关注AIP患者的肌肉健康维护。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验